@i-med.ac.at
rdcu.be/eMLob
@i-med.ac.at
rdcu.be/eMLob
www.stern.de/kultur/fried...
/1
www.stern.de/kultur/fried...
/1
Neue Studie zeigt: COVID-mRNA Impfung vor Immuntherapie verbessert Überleben bei Lungen- und Hautkrebs deutlich (HR 0,51), durch Aktivierung von Immunantworten gegen den Tumor. Von wegen "Turbo-Krebs" #ImpfenSchuetzt
www.nature.com/articles/s41...
Neue Studie zeigt: COVID-mRNA Impfung vor Immuntherapie verbessert Überleben bei Lungen- und Hautkrebs deutlich (HR 0,51), durch Aktivierung von Immunantworten gegen den Tumor. Von wegen "Turbo-Krebs" #ImpfenSchuetzt
www.nature.com/articles/s41...
Well deserved! 💪🏼 @i-med.ac.at @dinatiniakos.bsky.social
Well deserved! 💪🏼 @i-med.ac.at @dinatiniakos.bsky.social
THIS is one of the biggest problems of our time . . .
⬇️ ⬇️ ⬇️
.
THIS is one of the biggest problems of our time . . .
⬇️ ⬇️ ⬇️
.
It's history's job to tell the truth, not cover up past racism to pave the way for future racism.
It's history's job to tell the truth, not cover up past racism to pave the way for future racism.
www.aerzteblatt.de/news/antibio...
www.aerzteblatt.de/news/antibio...
#meduniibk
#meduniibk
As pathologists, we mostly focus on the tumor tissue itself, not on non-neoplastic tissue afar from the tumor. Thus, we focus on the intratumoral microbiomes and its meaning for patient outcome.
As pathologists, we mostly focus on the tumor tissue itself, not on non-neoplastic tissue afar from the tumor. Thus, we focus on the intratumoral microbiomes and its meaning for patient outcome.
#pathology
#pathology
👉 Preop chemo with PAXG 🆚 mFOLFIRINOX for extending event-free survival (EFS) in resectable or BR PDAC (phase 3 CASSANDRA trial)
🆙 PAXG 3-year EFS 31% vs. 13% P = .003
🫸 Immature analysis for survival but.. future practice changing?! 🧐
@ascopost.bsky.social
👉 Preop chemo with PAXG 🆚 mFOLFIRINOX for extending event-free survival (EFS) in resectable or BR PDAC (phase 3 CASSANDRA trial)
🆙 PAXG 3-year EFS 31% vs. 13% P = .003
🫸 Immature analysis for survival but.. future practice changing?! 🧐
@ascopost.bsky.social
Komm vorbei und informier dich über die Perspektiven und Möglichkeiten unseres Faches!
@i-med.ac.at
Komm vorbei und informier dich über die Perspektiven und Möglichkeiten unseres Faches!
@i-med.ac.at
www.nature.com/articles/s41...
@i-med.ac.at
www.nature.com/articles/s41...
@i-med.ac.at
full text available here 👉 rdcu.be/em0VG and thread 👇
full text available here 👉 rdcu.be/em0VG and thread 👇